Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

enVVeno Medical (NVNO) Shares Issued (2017 - 2020)

enVVeno Medical has reported Shares Issued over the past 4 years, most recently at $2.4 million for Q4 2020.

  • For Q4 2020, Shares Issued rose 340.97% year-over-year to $2.4 million; the TTM value through Dec 2020 reached $3.6 million, up 175.11%, while the annual FY2025 figure was $241000.0, 98.23% down from the prior year.
  • Shares Issued for Q4 2020 was $2.4 million at enVVeno Medical, up from $631626.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $6.5 million in Q2 2018 and troughed at -$1.0 million in Q4 2019.
  • A 4-year average of $1.7 million and a median of $659500.0 in 2017 define the central range for Shares Issued.
  • On a YoY basis, Shares Issued climbed as much as 340.97% in 2020 and fell as far as 75.39% in 2020.
  • Year by year, Shares Issued stood at $659500.0 in 2017, then soared by 890.51% to $6.5 million in 2018, then plummeted by 115.34% to -$1.0 million in 2019, then skyrocketed by 340.97% to $2.4 million in 2020.
  • Business Quant data shows Shares Issued for NVNO at $2.4 million in Q4 2020, $631626.0 in Q3 2020, and $570341.0 in Q1 2020.